Pharmacokinetic comparability of Prolastin(®)-C to Prolastin(® )in alpha(1)-antitrypsin deficiency: a randomized study

BACKGROUND: Alpha(1)-antitrypsin (AAT) deficiency is characterized by low blood levels of alpha(1)-proteinase inhibitor (alpha(1)-PI) and may lead to emphysema. Alpha(1)-PI protects pulmonary tissue from damage caused by the action of proteolytic enzymes. Augmentation therapy with Prolastin(® )(Alph...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Stocks, James M, Brantly, Mark L, Wang-Smith, Laurene, Campos, Michael A, Chapman, Kenneth R, Kueppers, Friedrich, Sandhaus, Robert A, Strange, Charlie, Turino, Gerard
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2010
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2958874/
https://ncbi.nlm.nih.gov/pubmed/20920295
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1472-6904-10-13
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items